Immunogenicity and Safety of a Purified Vero Rabies Vaccine – Serum Free, Compared With Two Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized Controlled Phase III Trial
- Published on 19/11/2024
- Reading time: 4 min.
Andrea-Clemencia Pineda-Peña, 1, Qian Jiang, 1, Celine Petit, 1, Joanna Korejwo-Peyramond, 2, Yves Donazzolo, 3, Mathilde Latreille, 3, Marie-Claude Homery, 4, Valerie Babin, 1, Sonia Benamor, 1, Sylvie Pichon, 1, Françoise Guinet-Morlot, 1, Ada-Maria Minutello 1
1 Sanofi, Campus Mérieux, Marcy l’Etoile, France
2 Sanofi, Campus Carteret, Lyon, France
3 Eurofins, Optimed, Gieres, France
4 Biotrial, Rennes, France
Correspondence: Andrea C. Pineda-Peña, Sanofi, Marcy l'Etoile, 1019 Av. Marcel Mérieux, 69280 Marcy-l'Étoile, France (Andrea.Pineda@sanofi.com).
To continue reading this article in Full-Text...
Join the Valneva community to receive personalized information as specified in the Valneva Privacy Policy available here about Valneva services, product events and programs by email.
I WANT TO BE A MEMBER
Search | Advanced search
Articles by topics
